Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors.
Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors.
复制标题
用于治疗阿尔茨海默病的选择性毒蕈碱激动剂的设计和开发：四氢嘧啶衍生物的表征和开发提高 M1 受体亲和力和选择性的新方法。
DOI：
10.1016/s0031-6865(99)00026-6
复制
发表时间：
2000
期刊：
影响因子：
--
通讯作者：
Peseckis,SM
中科院分区：
文献类型：
--
作者：
MesserJr,WS;Rajeswaran,WG;Cao,Y;Zhang,HJ;el-Assadi,AA;Dockery,C;Liske,J;O'Brien,J;Williams,FE;Huang,XP;Wroblewski,ME;Nagy,PI;Peseckis,SM
